GSR Ventures is a venture capital firm established in 2004, with offices in Menlo Park, California, and Beijing, China. The firm specializes in investing in early-stage technology companies that focus on artificial intelligence, consumer internet, and healthcare technology. GSR Ventures is dedicated to supporting entrepreneurs who are creating disruptive businesses with the potential to lead in multi-billion dollar markets. By concentrating on sectors such as AI-enabled enterprise software and digital health, GSR Ventures aims to foster innovation and drive growth in transformative industries. The firm manages approximately $3.7 billion across its various funds.
STE. 5620, China World Trade Center Tower III, No.1 Jianguomenwai St., Chaoyang District, Beijing 100004, China
Kevin Fong
Managing Director
Haichen Hu MD
Partner
Daisy Jiang
Partner
Sunny Kumar
Partner
Richard Lim
Founder and Managing Director
Justin Norden
Partner
Mandy Wen
Vice President
Zhiwei Yang
Partner
David Yin
Partner
Kevin Yin
Affiliated Partner
Yutong Zhang
Partner
Allen Zhu
Managing Director
Past deals in Mental Health
Sonar
Pre Seed Round in 2025
Sonar is a healthcare company focusing on the proactive identification and intervention of mental health challenges in youth.
HealthRhythms
Seed Round in 2022
HealthRhythms is a company that specializes in mental health assessment and treatment through an innovative platform that leverages deep machine learning and predictive analytics. Its solution focuses on real-time, objective monitoring of mental health conditions, providing continuous assessments and personalized digital interventions. By accurately measuring mental health status and anticipating clinical deterioration, HealthRhythms enables healthcare providers to identify and manage patients effectively. The platform enhances the care delivery experience for patients, health plans, payers, and research organizations by offering just-in-time interventions tailored to individual patient profiles. This groundbreaking approach aims to improve overall mental health outcomes and facilitate better management of behavioral health.
Limbix
Series A in 2021
Limbix is a prescription digital therapeutic company focused on developing innovative mental health treatments specifically for adolescents. The company offers a digital therapeutics platform designed to address the mental health challenges faced by young people, including depression and anxiety. Limbix's first product, SparkRx, enables licensed healthcare professionals to prescribe evidence-based, therapeutic interventions to improve the mental well-being of their patients. The diverse team at Limbix, consisting of clinicians, product designers, researchers, and engineers, combines clinical expertise with technological innovation to create effective digital solutions for adolescent mental health.
Limbix
Series A in 2020
Limbix is a prescription digital therapeutic company focused on developing innovative mental health treatments specifically for adolescents. The company offers a digital therapeutics platform designed to address the mental health challenges faced by young people, including depression and anxiety. Limbix's first product, SparkRx, enables licensed healthcare professionals to prescribe evidence-based, therapeutic interventions to improve the mental well-being of their patients. The diverse team at Limbix, consisting of clinicians, product designers, researchers, and engineers, combines clinical expertise with technological innovation to create effective digital solutions for adolescent mental health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.